Good afternoon :)
Place Order
Add to Watchlist

Themis Medicare Ltd

THEMISMED Share Price

130.442.53% (-3.39)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹1,231 cr, stock is ranked 1,342

High Risk

Stock is 4.32x as volatile as Nifty

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹1,231 cr, stock is ranked 1,342

High Risk

Stock is 4.32x as volatile as Nifty

THEMISMED Performance & Key Metrics

THEMISMED Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
41.293.26—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.656.550.84%

THEMISMED Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

THEMISMED Company Profile

Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.

Investor Presentation

View older View older 

May 20, 2025

PDF
View Older Presentations

THEMISMED Similar Stocks (Peers)

Compare with peers Compare with peers 

THEMISMED Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
8.35%
8.35%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
22.95
22.95
1Y Return
5.01%
5.01%
Buy Reco %
74.19
74.19
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.32
19.32
1Y Return
9.60%
9.60%
Buy Reco %
56.67
56.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
11.78%
11.78%
Buy Reco %
72.00
72.00
Mankind Pharma Ltd
MANKIND
PE Ratio
48.88
48.88
1Y Return
5.10%
5.10%
Buy Reco %
81.25
81.25
Compare with Peers

THEMISMED Forecast

THEMISMED Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

THEMISMED

THEMISMED

Income

Balance Sheet

Cash Flow

THEMISMED Income Statement

THEMISMED Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 16.52%, vs industry avg of 9.02%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.09% to 0.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue220.73215.11188.69213.96243.77412.49379.44405.32416.11420.58
Raw Materialssubtract74.5373.1568.8166.6779.48145.08126.16138.28356.46360.94
Power & Fuel Costsubtract9.778.419.7011.4911.3212.1811.8313.46
Employee Costsubtract40.0044.6545.6944.2839.9951.9766.1582.41
Selling & Administrative Expensessubtract35.5737.2035.2826.3426.9644.7351.0459.01
Operating & Other expensessubtract23.9821.0822.0017.1523.4345.0231.7037.09
Depreciation/Amortizationsubtract7.477.427.998.278.559.4810.4912.259.939.93
Interest & Other Itemssubtract11.8411.8711.8212.8812.718.779.569.3810.0410.04
Taxes & Other Itemssubtract1.600.04-1.862.095.6322.3815.619.929.849.84
EPS1.821.24-1.172.703.897.936.184.733.243.24
DPS0.000.000.000.180.430.500.500.500.000.50
Payout ratio0.000.000.000.060.110.060.080.110.000.15
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

THEMISMED Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 20PDF
Feb 14PDF
Oct 25PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 17PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 15PDF
Feb 9PDF
Nov 9PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

THEMISMED Stock Peers

THEMISMED Past Performance & Peer Comparison

THEMISMED Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Themis Medicare Ltd41.283.26—
Sun Pharmaceutical Industries Ltd36.185.890.97%
Cipla Ltd22.954.511.07%
Dr Reddy's Laboratories Ltd19.323.870.61%

THEMISMED Stock Price Comparison

Compare THEMISMED with any stock or ETF
Compare THEMISMED with any stock or ETF
THEMISMED
Loading...

THEMISMED Holdings

THEMISMED Shareholdings

THEMISMED Promoter Holdings Trend

THEMISMED Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

THEMISMED Institutional Holdings Trend

THEMISMED Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

THEMISMED Shareholding Pattern

THEMISMED Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.15%0.00%0.01%0.14%32.70%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

THEMISMED Shareholding History

THEMISMED Shareholding History

Dec '23MarJunSepDec '24Mar0.01%0.03%0.05%0.10%0.10%0.14%

Mutual Funds Invested in THEMISMED

Mutual Funds Invested in THEMISMED

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 1 Mutual Funds holding Themis Medicare Ltd

Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Bandhan BSE Healthcare Index Fund Direct Plan-Growth

Growth
0.0005%0.03%-0.01%103/109 (-9)

Compare 3-month MF holding change on Screener

THEMISMED Insider Trades & Bulk Stock Deals

THEMISMED Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing THEMISMED stock

smallcases containing THEMISMED stock

Looks like this stock is not in any smallcase yet.

THEMISMED Events

THEMISMED Events

THEMISMED Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

THEMISMED Dividend Trend

No dividend trend available

THEMISMED Upcoming Dividends

THEMISMED Upcoming Dividends

No upcoming dividends are available

THEMISMED Past Dividends

THEMISMED Past Dividends

Cash Dividend

Ex DateEx DateJul 12, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Jul 12, 2024

Cash Dividend

Ex DateEx DateSep 1, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 1, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹4.30

Dividend/Share

₹4.30

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹1.75

Dividend/Share

₹1.75

Ex DateEx Date

Sep 17, 2020

THEMISMED Stock News & Opinions

THEMISMED Stock News & Opinions

Corporate
Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Earnings
Themis Medicare reports consolidated net loss of Rs 9.66 crore in the March 2025 quarter

Net loss of Themis Medicare reported to Rs 9.66 crore in the quarter ended March 2025 as against net profit of Rs 6.64 crore during the previous quarter ended March 2024. Sales declined 26.70% to Rs 71.70 crore in the quarter ended March 2025 as against Rs 97.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 31.46% to Rs 29.83 crore in the year ended March 2025 as against Rs 43.52 crore during the previous year ended March 2024. Sales rose 6.22% to Rs 405.51 crore in the year ended March 2025 as against Rs 381.76 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales71.7097.82 -27 405.51381.76 6 OPM %-10.739.51 -12.1013.49 - PBDT-8.6011.80 PL 49.6065.69 -24 PBT-11.138.75 PL 39.6753.44 -26 NP-9.666.64 PL 29.8343.52 -31 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Themis Medicare to declare Quarterly Results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Themis Medicare consolidated net profit declines 92.94% in the December 2024 quarter

Net profit of Themis Medicare declined 92.94% to Rs 0.52 crore in the quarter ended December 2024 as against Rs 7.37 crore during the previous quarter ended December 2023. Sales rose 13.70% to Rs 93.81 crore in the quarter ended December 2024 as against Rs 82.51 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.8182.51 14 OPM %6.369.77 - PBDT4.2011.31 -63 PBT1.668.22 -80 NP0.527.37 -93 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Themis Medicare consolidated net profit rises 26.24% in the September 2024 quarter

Net profit of Themis Medicare rose 26.24% to Rs 14.29 crore in the quarter ended September 2024 as against Rs 11.32 crore during the previous quarter ended September 2023. Sales rose 11.67% to Rs 117.01 crore in the quarter ended September 2024 as against Rs 104.78 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales117.01104.78 12 OPM %14.6411.84 - PBDT20.2517.03 19 PBT17.8013.96 28 NP14.2911.32 26 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live

Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter

10 months agoBusiness Standard
Earnings
Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter

Net profit of Themis Medicare rose 35.68% to Rs 24.68 crore in the quarter ended June 2024 as against Rs 18.19 crore during the previous quarter ended June 2023. Sales rose 27.25% to Rs 122.99 crore in the quarter ended June 2024 as against Rs 96.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales122.9996.65 27 OPM %23.7322.49 - PBDT33.7525.54 32 PBT31.3522.52 39 NP24.6818.19 36 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Themis Medicare Ltd (THEMISMED) today?

    The share price of THEMISMED as on 19th June 2025 is ₹130.44. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Themis Medicare Ltd (THEMISMED) share?

    The past returns of Themis Medicare Ltd (THEMISMED) share are
    • Past 1 week: -7.23%
    • Past 1 month: -12.45%
    • Past 3 months: -10.75%
    • Past 6 months: -50.59%
    • Past 1 year: -38.32%
    • Past 3 years: 78.39%
    • Past 5 years: 319.14%

  3. What are the peers or stocks similar to Themis Medicare Ltd (THEMISMED)?

    The peers or stocks similar to Themis Medicare Ltd (THEMISMED) include:

  4. What is the market cap of Themis Medicare Ltd (THEMISMED) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Themis Medicare Ltd (THEMISMED) is ₹1231.77 Cr as of 19th June 2025.

  5. What is the 52 week high and low of Themis Medicare Ltd (THEMISMED) share?

    The 52-week high of Themis Medicare Ltd (THEMISMED) is ₹317 and the 52-week low is ₹115.

  6. What is the PE and PB ratio of Themis Medicare Ltd (THEMISMED) stock?

    The P/E (price-to-earnings) ratio of Themis Medicare Ltd (THEMISMED) is 41.28. The P/B (price-to-book) ratio is 3.26.

  7. Which sector does Themis Medicare Ltd (THEMISMED) belong to?

    Themis Medicare Ltd (THEMISMED) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Themis Medicare Ltd (THEMISMED) shares?

    You can directly buy Themis Medicare Ltd (THEMISMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.